"Amyloid-lowering treatments represent an important advance in the treatment of Alzheimer's disease but they are associated ...

Good afternoon and welcome to today's conference call for Omeros Corporation. (Operator Instructions) Please be advised that this call is being recorded at the company's request and a replay will be ...

Based on the insights collected to date, zaltenibart's clinical profile together with its low treatment burden of only four to six times per year is clearly differentiated from treatment options on ..

If you’re curious about what was invented the year you were born, RS Components compiled a fascinating list, which we’re ...

To date, no clinically relevant safety issues have been reported other than transient injection site reactions (49%) and ...

In a new study, researchers at McMaster University have identified a potential treatment for Sandhoff and Tay-Sachs ...

When I was diagnosed with Parkinson’s in August 2019, a doctor told me that Sinemet (Levodopa/Carbidopa), the starter drug of ...

Researchers released new clinical guidelines for treating restless legs syndrome (RLS), emphasizing patient-centered care and ...

U.S. stocks traded lower toward the end of trading, with the Dow Jones index falling by more than 150 points on Thursday. The ...

BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) today announces that EMA's Committee for Medicinal Products for Human Use (CHMP) has issued a positive recommendation regarding BioArctic's partner Eisai ...

The Milken Institute Science Philanthropy Accelerator for Research and Collaboration (SPARC) announced key resources and philanthropic capital to reshape scientific research fields and advance better ...

DiagnaMed Holdings Corp. ("DiagnaMed" or the "Company") , a life sciences company focused on molecular hydrogen and AI diagnostics, is pleased to announce it has entered into a collaboration agreement ...